ES2063412T3 - Tableta y granulado que contienen como principio activo mesna. - Google Patents

Tableta y granulado que contienen como principio activo mesna.

Info

Publication number
ES2063412T3
ES2063412T3 ES91111125T ES91111125T ES2063412T3 ES 2063412 T3 ES2063412 T3 ES 2063412T3 ES 91111125 T ES91111125 T ES 91111125T ES 91111125 T ES91111125 T ES 91111125T ES 2063412 T3 ES2063412 T3 ES 2063412T3
Authority
ES
Spain
Prior art keywords
tablet
active substance
mesna
granulate containing
granulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91111125T
Other languages
English (en)
Inventor
Dieter Sauerbier
Jurgen Prof Dr Engel
Eckhard Dr Milsmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asta Medica GmbH
Original Assignee
Asta Medica GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica GmbH filed Critical Asta Medica GmbH
Application granted granted Critical
Publication of ES2063412T3 publication Critical patent/ES2063412T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UNA TABLETA ASI COMO A UN GRANULADO Y A UN PROCEDIMIENTO PARA SU FABRICACION, QUE CONTIENEN MESNA COMO SUBSTANCIA ACTIVA, CONTENIENDO LA TABLETA, RESPECTIVAMENTE, CON RELACION A UNA PARTE EN PESO DE MESNA, 0,01 RTES EN PESO DE UN AGLUTINANTE, 0,03 ANTE 0,01 ,05 ABLE FISIOLOGICAMENTE; EL GRANULADO CONTIENE, A EXCEPCION DEL EXPLOSIVO, LAS MISMAS SUBSTANCIAS AUXILIARES MENCIONADAS ANTERIORMENTE.
ES91111125T 1990-07-16 1991-07-04 Tableta y granulado que contienen como principio activo mesna. Expired - Lifetime ES2063412T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (1)

Publication Number Publication Date
ES2063412T3 true ES2063412T3 (es) 1995-01-01

Family

ID=25895027

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91111125T Expired - Lifetime ES2063412T3 (es) 1990-07-16 1991-07-04 Tableta y granulado que contienen como principio activo mesna.

Country Status (31)

Country Link
US (1) US5262169A (es)
EP (1) EP0468245B1 (es)
JP (1) JP3068894B2 (es)
KR (1) KR100189666B1 (es)
CN (1) CN1072484C (es)
AT (1) ATE104548T1 (es)
AU (1) AU638586B2 (es)
BG (2) BG60851B1 (es)
CA (1) CA2047027C (es)
DE (2) DE59101431D1 (es)
DK (1) DK0468245T3 (es)
EG (1) EG20019A (es)
ES (1) ES2063412T3 (es)
FI (1) FI97949C (es)
HK (1) HK129894A (es)
HR (1) HRP920889B1 (es)
HU (1) HU206630B (es)
IE (1) IE65373B1 (es)
IL (1) IL98836A (es)
LT (1) LT3527B (es)
LV (1) LV10040B (es)
MC (1) MC2273A1 (es)
MX (1) MX174407B (es)
NO (1) NO178362C (es)
NZ (1) NZ238941A (es)
PT (1) PT98325B (es)
RO (1) RO113713B1 (es)
RU (1) RU2070040C1 (es)
SG (1) SG142394G (es)
SI (1) SI9111226A (es)
ZA (1) ZA915515B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0560092B1 (de) * 1992-03-11 1997-12-03 ASTA Medica Aktiengesellschaft Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
ATE65402T1 (de) * 1988-03-19 1991-08-15 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.

Also Published As

Publication number Publication date
IE912463A1 (en) 1992-01-29
AU8044591A (en) 1992-01-16
CN1058337A (zh) 1992-02-05
JP3068894B2 (ja) 2000-07-24
DK0468245T3 (da) 1994-05-16
FI97949B (fi) 1996-12-13
IL98836A0 (en) 1992-07-15
RO113713B1 (ro) 1998-10-30
FI913409A0 (fi) 1991-07-15
CA2047027A1 (en) 1992-01-17
LV10040A (lv) 1994-05-10
KR920002154A (ko) 1992-02-28
LV10040B (en) 1995-06-20
CN1072484C (zh) 2001-10-10
RU2070040C1 (ru) 1996-12-10
BG60901B1 (bg) 1996-06-28
ATE104548T1 (de) 1994-05-15
DE59101431D1 (de) 1994-05-26
PT98325A (pt) 1992-05-29
SI9111226A (en) 1995-04-30
KR100189666B1 (ko) 1999-06-01
NO912771L (no) 1992-01-17
IL98836A (en) 1994-11-28
SG142394G (en) 1995-01-13
NZ238941A (en) 1993-03-26
HRP920889A2 (en) 1996-04-30
HRP920889B1 (en) 1998-02-28
IE65373B1 (en) 1995-10-18
DE4122167A1 (de) 1992-01-23
NO178362B (no) 1995-12-04
MX174407B (es) 1994-05-13
HU912374D0 (en) 1991-12-30
HU206630B (en) 1992-12-28
BG60851B1 (bg) 1996-05-31
CA2047027C (en) 1996-09-17
MC2273A1 (fr) 1993-06-23
FI913409A (fi) 1992-01-17
PT98325B (pt) 1999-01-29
NO178362C (no) 1996-03-13
JPH04230319A (ja) 1992-08-19
LTIP920A (en) 1995-03-27
EG20019A (en) 1997-01-30
HUT59317A (en) 1992-05-28
ZA915515B (en) 1992-04-29
HK129894A (en) 1994-12-02
LT3527B (en) 1995-11-27
AU638586B2 (en) 1993-07-01
EP0468245A1 (de) 1992-01-29
NO912771D0 (no) 1991-07-15
EP0468245B1 (de) 1994-04-20
US5262169A (en) 1993-11-16
FI97949C (fi) 1997-03-25

Similar Documents

Publication Publication Date Title
ES2058151T3 (es) Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
MX6223E (es) Procedimiento mejorado para la preparacion de provectiles balisticos que contienen una composicion biologicamente activa
ES2054716T3 (es) Bis-naftalimidas, su obtencion y empleo.
ES485908A0 (es) Procedimiento para la fabricaion de plantillas para el cal- zado.
SE8303531D0 (sv) Farmaceutisk komposition
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
EE03105B1 (et) Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
MX9308013A (es) 4-fenil-piridonas y 4-fenil-2-fenil-2-alcoxipiridinas sustituidas, procedimiento para su preparacion y medicamentos que los contienen.
ES2063412T3 (es) Tableta y granulado que contienen como principio activo mesna.
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
ES2043696T3 (es) Derivados de prostaglandina e1 (derivados-pge1) como substancias activas farmaceuticas y medicamentos que contienen estos compuestos, especialmente para aplicacion transcutanea.
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
ES493481A0 (es) Procedimiento para preparar 2,7-dioxo-2,7-dihidroben- zo-(1:2-b;5:6-b1)difurano o -dipirrol
SE8803935D0 (sv) Laekemedelskomposition
SE8302979D0 (sv) Piperazine derivatives, their production and pharmaceutical compositions containing them
ES2053535T3 (es) Derivados heterociclicos de cinco miembros de n,n'-diacilhidrazinas n' sustituidas.
ES2054881T3 (es) Pantetina como agente inhibidor de la fibrosis hepatica.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468245

Country of ref document: ES